CELLSEARCH – Circulating tumor cell detection

The promise of personalized medicine is now one step closer — Massachusetts General Hospital is collaborating with Johnson & Johnson on technology that takes a simple, non-invasive blood test, and scans circulating tumor cells — offering oncologists a better prognosis for treating patients. For more information, please visit http://www.veridex.com/